已收盤 06-18 16:00:00 美东时间
+0.030
+0.65%
The IND submission is supported by clinical observations from Quoin's ongoing investigator-led pediatric PSS study. The initial subject has been treated with QRX003 for over 15 months and significant clinical
06-02 20:36
Quoin Pharmaceuticals (NASDAQ:QNRX) reported quarterly losses of $(1.77) per share which missed the analyst consensus estimate of $(1.72) by 2.91 percent. This is a 72.77 percent increase over losses of $(6.50) per share
05-07 20:32
今日重点评级关注:Canaccord Genuity:维持Sagimet Biosciences"买入"评级,目标价从28美元升至49美元;HC Wainwright & Co.:维持Fate Therapeutics"买入"评级,目标价从5美元升至7美元
05-05 11:40
LUCID CAPITAL MARKETS analyst Dev Prasad initiates coverage on Quoin Pharmaceuticals (NASDAQ:QNRX) with a Buy rating and announces Price Target of $30.
05-05 01:04
Kingswood Acquisition Corp. Class A涨59.20%;Enterprise Financial Services Corp Depositary Shs Repr 1/40th 5 % Non-Cum Red Perp Pfd Shs Series A涨27.12%;PMGC Holdings Inc.涨26.54%
04-01 13:01
优品车涨40.80%;Globavend Holdings Ltd.涨40.78%;BeLive Holdings涨14.67%
03-27 15:01
优品车涨45.22%;Globavend Holdings Ltd.涨42.72%;Turbo Energy涨12.76%
03-27 13:01
Globavend Holdings Ltd.涨49.51%;优品车涨42.80%;雷特控股涨18.88%
03-27 10:01
Quoin Pharmaceuticals (NASDAQ:QNRX) reported quarterly losses of $(1.74) per share which beat the analyst consensus estimate of $(4.02) by 56.72 percent. This is a 85.96 percent increase over losses of $(12.39) per share
03-26 20:32
Companies Reporting Before The Bell • ProShares UltraShort Russell2000 (NYSE:TW...
03-26 19:11